Alexandria Real Estate Equities’ second quarter 2026 filings confirm steady occupancy near 91% in its highly specialized life science property portfolio, sustaining rental revenue despite broader economic headwinds. The company’s sizeable development pipeline of approximately 3.5 million rentable square feet under construction underscores its growth strategy centered on innovation campuses but faces timing uncertainty due to legal disputes affecting a key New York City parcel. Tenant credit quality and long lease terms support revenue stability, although net operating income dipped modestly reflecting market pressures. Ongoing refinancing efforts aim to optimize capital costs amid interest rate volatility, with cash reserves nearing $470 million providing liquidity buffer. Key watchpoints include leasing momentum, development milestones, and risk management around tenant concentration and permit delays.